首页> 美国卫生研究院文献>other >Incidence and risk of dialysis therapy within 30 days after contrast enhanced computed tomography in patients coded with chronic kidney disease: a nation-wide population-based study
【2h】

Incidence and risk of dialysis therapy within 30 days after contrast enhanced computed tomography in patients coded with chronic kidney disease: a nation-wide population-based study

机译:慢性肾脏病编码患者在对比增强计算机断层扫描后30天内进行透析治疗的发生率和风险:一项基于全国的人群研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPatients with chronic kidney disease (CKD) are considered at risk of contrast-induced acute kidney injury and possible subsequent need for dialysis therapy. Computed tomography (CT) is the most commonly performed examination requiring intravenous iodinated contrast media (ICM) injection. The actual risk of dialysis in CKD patients undergoing CT with ICM remains controversial. Furthermore, it is also uncertain whether these at-risk patients can be identified by means of administrative data. Our study is conducted in order to determine the incidence and risk of dialysis within 30 days after undergoing contrast enhanced CT in CKD coded patients.
机译:背景患有慢性肾脏病(CKD)的患者被认为存在造影剂诱发的急性肾脏损伤的风险,并可能随后需要进行透析治疗。计算机断层扫描(CT)是最常进行的检查,需要静脉注射碘化造影剂(ICM)。在接受ICM CT的CKD患者中,透析的实际风险仍然存在争议。此外,还不确定是否可以通过管理数据识别这些高危患者。进行我们的研究是为了确定CKD编码患者接受对比增强CT后30天内的透析发生率和透析风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号